{
    "2018-10-31": [
        [
            {
                "time": "",
                "original_text": "医疗保健：医药创新是行业发展永恒的主题 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医药创新",
                        "行业发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：CRO、CDMO均高速增长 Q3业绩超预期",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "CDMO",
                        "Q3业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-Q3",
                "original_text": "无锡药明康德新药开发股份有限公司2018第三季度报告",
                "features": {
                    "keywords": [
                        "药明康德",
                        "新药开发",
                        "2018第三季度报告"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德前三季净利同比增八成 H股上市推进中",
                "features": {
                    "keywords": [
                        "药明康德",
                        "净利",
                        "同比增八成",
                        "H股上市"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}